Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    Open Studies | "von Hippel-Lindau Disease"
Show Display Options
Rank Status Study
1 Recruiting Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease
Condition: Von Hippel-Lindau Disease
Intervention:
2 Recruiting Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
Condition: Von Hippel-Lindau Disease
Intervention:
3 Not yet recruiting A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Condition: Von Hippel-Lindau Syndrome
Interventions: Drug: Ranibizumab;   Drug: E10030
4 Recruiting Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Von Hippel-Lindau Syndrome;   Hippel-Lindau Disease
Interventions: Drug: 68Gallium DOTATATE;   Procedure: Radio-guided surgery
5 Recruiting National Eye Institute Biorepository for Retinal Diseases
Conditions: Age-Related Macular Degeneration;   Diabetic Retinopathy;   Von Hippel-Lindau Syndrome;   Retinal Disease;   Retinal Vein Occlusion
Intervention:
6 Recruiting Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Conditions: Kidney Cancer;   Urologic Malignant Disorders
Intervention:
7 Recruiting Diagnosis of Pheochromocytoma
Condition: Pheochromocytoma
Intervention:

Study has passed its completion date and status has not been verified in more than two years.